3 Hospital Network, Water Treatment Company and Ceramic Tiles Maker Stocks With a Strong Future Roadmap: Max Healthcare Institute, VA Tech Wabag and Kajaria Ceramics

Hospital, water treatment and tile stocks bring together companies with a visible plan for the years ahead. Max Healthcare Institute, VA Tech Wabag and Kajaria Ceramics cover a hospital network, a water treatment company and a ceramic tiles maker.

This list covers three hospital, water treatment and tile stocks with complete current figures: Max Healthcare Institute, VA Tech Wabag and Kajaria Ceramics. Every figure comes from the latest reported financials and the 9 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Hospital, Water Treatment and Tile Stocks?

Hospital, water treatment and tile stocks are listed companies that run multi specialty hospitals across India, design and build water and wastewater treatment plants, and manufacture ceramic and vitrified tiles. Their earnings depend on patient volumes, municipal and industrial water projects and housing demand.

Hospital, Water Treatment and Tile Stocks at a Glance

On valuation, Max Healthcare Institute trades at a P/E below the industry P/E, while VA Tech Wabag and Kajaria Ceramics trade above it, which reflects the growth the market already expects. Readers comparing hospital, water treatment and tile stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in hospital, water treatment and tile stocks can use the coming numbers to test whether growth is holding.

Why Do Hospital, Water Treatment and Tile Stocks Have a Strong Roadmap in India?

Hospital, water treatment and tile stocks have a strong roadmap in India because growing demand for quality hospital care, heavy spending on water and wastewater projects and steady housing and renovation work keep widening the market for these companies.

• Hospitals. Patients seek advanced multi specialty care.
• Water treatment. Cities and plants need clean water systems.
• Tiles. New homes and offices need flooring.

Why Max Healthcare Institute Features Among These Hospital, Water Treatment and Tile Stocks

Among the hospital, water treatment and tile stocks on this list, Max Healthcare Institute runs a large network of multi-specialty hospitals concentrated in Delhi NCR, Punjab, Uttarakhand and Maharashtra, with a strong presence in oncology, cardiac sciences, neurosciences and orthopaedics.

In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%.

Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6.

Roadmap: The roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.

What to watch: Track how quickly new beds reach stable occupancy and whether average revenue per occupied bed keeps rising.

Why VA Tech Wabag Features Among These Hospital, Water Treatment and Tile Stocks

Among the care, water solutions and floor shares on this list, VA Tech Wabag designs, builds and operates water and wastewater treatment plants, including desalination and recycling plants, for municipal and industrial customers in India and abroad.

The company has a return on equity of 14.4%, a debt to equity ratio of 0.09 and a market capitalisation of Rs 11,717 crore. The stock trades at a P/E of 29.7, above the industry P/E of 22.7.

Revenue rose from Rs 3,012 crore in FY22 to Rs 4,038 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 132 crore in FY22 to Rs 370 crore in FY26, which works out to a compound annual growth rate of 29.4%. In the June 2026 quarter, revenue grew 26.0% year on year to Rs 939 crore, while net profit rose 36.9% to Rs 90.1 crore.

Roadmap: Government missions for drinking water supply and sewage treatment, along with industrial water reuse, feed a long project pipeline. Operation and maintenance contracts add recurring revenue, and international orders widen the customer base.

What to watch: Monitor the order book, the share of operation and maintenance contracts and working capital cycles on large projects.

Why Kajaria Ceramics Features Among These Hospital, Water Treatment and Tile Stocks

Among the three companies on this list, Kajaria Ceramics is India's largest ceramic and vitrified tile maker, with plants across several states and a large dealer network.

Revenue rose from Rs 3,733 crore in FY22 to Rs 4,883 crore in FY26, a compound annual growth rate of 6.9%. Net profit grew from Rs 383 crore in FY22 to Rs 490 crore in FY26, which works out to a compound annual growth rate of 6.4%.

In the June 2026 quarter, revenue grew 20.5% year on year to Rs 1,345 crore, while net profit rose 55.0% to Rs 171 crore. The company has a return on equity of 15.8%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 18,977 crore. The stock trades at a P/E of 34.6, above the industry P/E of 31.1.

Roadmap: The company has added capacity in tiles and widened into adhesives, sanitaryware and faucets, which allows it to sell more products to each customer. Demand from housing, redevelopment and commercial building supports tile volumes.

What to watch: Check the capacity utilisation in newer plants and growth in the bath products business.

Max Healthcare Institute vs VA Tech Wabag vs Kajaria Ceramics on Key Financials

The table below sets the three hospital, water treatment and tile stocks side by side on revenue, profit and margin, using reported figures.

Kajaria Ceramics posts the highest return on equity in this group at 15.8%. Max Healthcare Institute combines the largest FY26 revenue at Rs 8,536 crore with the fastest revenue growth, a 20.4% compound annual rate. A useful habit with hospital, water treatment and tile stocks is to check each new quarterly result against the capacity plans the company described earlier. Many investors spread money across several multi specialty hospital, effluent plant and ceramic tile stocks instead of one name, which keeps a single result from deciding the outcome.

The June 2026 quarter, the latest reported, gives a fresh read on momentum:

Key Risks to Check Before Investing in Hospital, Water Treatment and Tile Stocks

Every theme carries risks that deserve a check before any decision. For these hospital, water treatment and tile stocks, the main points are: Long-term care, water solutions and floor shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio. Tracking promoter holding and management commentary adds context when you study care, water solutions and floor shares.

• Capacity ramp up. New hospitals take time to fill beds and reach full returns.
• Government spending. Public project funding can shift between periods.
• Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter hospital, water treatment and tile stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Hospital, Water Treatment and Tile Stocks

Hospital, water treatment and tile stocks suit investors who prefer to study business strength before price moves. Max Healthcare Institute, VA Tech Wabag and Kajaria Ceramics each have a clear plan to grow. Based on the 9 November 2026 close, Max Healthcare Institute trades at Rs 926, VA Tech Wabag at Rs 2,007.6 and Kajaria Ceramics at Rs 1,214.7. Valuation matters as much as growth, so compare each company's P/E with its industry P/E before adding any of these hospital, water treatment and tile stocks to a watchlist.

Download the Univest iOS App or Univest Android App to track hospital, water treatment and tile stocks, set price alerts and get research-backed stock ideas.

What are hospital, water treatment and tile stocks?

Ans. Hospital, water treatment and tile stocks are listed companies that run multi specialty hospitals across India, design and build water and wastewater treatment plants, and manufacture ceramic and vitrified tiles. Their earnings depend on patient volumes, municipal and industrial water projects and housing demand. This list looks at three of them, Max Healthcare Institute, VA Tech Wabag and Kajaria Ceramics, using reported FY22 to FY26 financials and the 9 November 2026 closing prices.

Which hospital, water treatment and tile stocks are covered in this list?

Ans. This list covers Max Healthcare Institute, VA Tech Wabag and Kajaria Ceramics. Based on the 9 November 2026 close, Max Healthcare Institute traded at Rs 926, VA Tech Wabag at Rs 2,007.6 and Kajaria Ceramics at Rs 1,214.7. Their return on equity ranges from 13.4% to 15.8%, and their revenue compound annual growth from FY22 to FY26 ranges from 6.9% to 20.4%.

Why do hospital, water treatment and tile stocks have a strong future roadmap in India?

Ans. Hospital, water treatment and tile stocks have a strong roadmap in India because growing demand for quality hospital care, heavy spending on water and wastewater projects and steady housing and renovation work keep widening the market for these companies. The main drivers are as follows. Hospitals. Patients seek advanced multi specialty care. Water treatment. Cities and plants need clean water systems. Tiles. New homes and offices need flooring. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Max Healthcare Institute performed financially?

Ans. Revenue rose from Rs 4,059 crore in FY22 to Rs 8,536 crore in FY26, a compound annual growth rate of 20.4%. Net profit grew from Rs 605 crore in FY22 to Rs 1,442 crore in FY26, which works out to a compound annual growth rate of 24.3%. In the June 2026 quarter, revenue grew 16.6% year on year to Rs 2,407 crore, while net profit rose 4.9% to Rs 323 crore. The company has a return on equity of 13.4%, a debt to equity ratio of 0.32 and a market capitalisation of Rs 80,717 crore. The stock trades at a P/E of 55.4, below the industry P/E of 59.6. Looking ahead, the roadmap rests on adding beds through brownfield expansion at existing campuses and through new hospitals in cities where the group already has referral strength. Higher bed occupancy and a richer case mix lift revenue per occupied bed, which is the number hospital analysts follow most closely.

How has VA Tech Wabag performed financially?

Ans. Revenue rose from Rs 3,012 crore in FY22 to Rs 4,038 crore in FY26, a compound annual growth rate of 7.6%. Net profit grew from Rs 132 crore in FY22 to Rs 370 crore in FY26, which works out to a compound annual growth rate of 29.4%. In the June 2026 quarter, revenue grew 26.0% year on year to Rs 939 crore, while net profit rose 36.9% to Rs 90.1 crore. The company has a return on equity of 14.4%, a debt to equity ratio of 0.09 and a market capitalisation of Rs 11,717 crore. The stock trades at a P/E of 29.7, above the industry P/E of 22.7. Looking ahead, government missions for drinking water supply and sewage treatment, along with industrial water reuse, feed a long project pipeline. Operation and maintenance contracts add recurring revenue, and international orders widen the customer base.

How has Kajaria Ceramics performed financially?

Ans. Revenue rose from Rs 3,733 crore in FY22 to Rs 4,883 crore in FY26, a compound annual growth rate of 6.9%. Net profit grew from Rs 383 crore in FY22 to Rs 490 crore in FY26, which works out to a compound annual growth rate of 6.4%. In the June 2026 quarter, revenue grew 20.5% year on year to Rs 1,345 crore, while net profit rose 55.0% to Rs 171 crore. The company has a return on equity of 15.8%, a debt to equity ratio of 0.07 and a market capitalisation of Rs 18,977 crore. The stock trades at a P/E of 34.6, above the industry P/E of 31.1. Looking ahead, the company has added capacity in tiles and widened into adhesives, sanitaryware and faucets, which allows it to sell more products to each customer. Demand from housing, redevelopment and commercial building supports tile volumes.

What risks should investors check before buying hospital, water treatment and tile stocks?

Ans. Investors should check a few risks before buying hospital, water treatment and tile stocks. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Government spending. Public project funding can shift between periods. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of hospital, water treatment and tile stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 9 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.